OKUR ONKURE THERAPEUTICS INC CLASS A
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about ONKURE THERAPEUTICS INC CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on OKUR from 3 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 2 have their first observed target in the past year.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Evercore ISI | Jonathan Miller | Buy | 1 Jul 2026 | — |
| H.C. Wainwright | Robert Burns | Buy | 20 Jul 2026 | 21.00 USD |
| Jonestrading | Soumit Roy | Hold | 7 May 2026 | — |
| Leerink Partners | Andrew Berens | Buy | 17 Sep 2026 | 11.00 USD |
| Lifesci Capital | Sam Slutsky | Buy | 13 Mar 2026 | 16.00 USD |
| Oppenheimer | Leland Gershell | Buy | 14 Aug 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:41 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.